Original Source(s)
Related Content
First MCT8 deficiency therapy approved
Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.
September 29, 2026
-
3 min
Nirsevimab may curb RSV severity
Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.
September 18, 2026
-
3 min